SALT LAKE CITY, Oct. 31, 2011 /PRNewswire/ -- CMEF Booth #H2-D16 -- Varian Medical Systems, Inc., (NYSE: VAR) a premier supplier of X-ray tubes and digital X-ray detectors, is pleased to announce its participation at the China International Medical Equipment Fair (CMEF) in Fuzhou, Fuzhou Province, China, October 31 – Nov 03, 2011.
Varian will showcase two major product lines; PaxScan® flat panel digital detectors and PaxPower™ X-ray tubes to include:
- The PaxScan® 3024M flat-panel detector, designed for full-field digital mammography. The innovative direct capture panel has a compact design, incorporating a narrow edge enabling radiologists to acquire images close to the chest wall with results in seconds. "The PaxScan® 3024M architecture, based on Varian's amorphous silicon (a-Si) design, promises to extend the capabilities of digital mammography into markets where its environmental stability makes it an attractive option over existing technologies," said Stephen Kimmel, vice president sales and marketing for Varian's X-Ray Products group. "The panel is also frame-rate capable for advanced mammographic applications."
- The PaxScan® 4336R, a 43cm x 36cm cassette size detector for digital radiography (DR) that is the first NEMA size DR panel designed in conformance with National Electronic Manufacturers Association (NEMA) standards to replace film cassettes used in existing radiographic and multi-bucky applications. The panel is also available with a portable hand-held enclosure for use in mobile imaging systems.
- The PaxPower™ FP1000 X-ray tube, a new-generation high-performance tube designed specifically for digital radiological imaging systems. The tube is a rotating anode tube developed for high demand applications and can also be used on mobile surgical CT and interventional systems. The X-ray tube is lightweight, small in size and is capable of 1000 watts continuous heat dissipation. "When used in conjunction with the PaxScan® dynamic imaging panels the FP 1000 provides a powerful, space efficient imaging system that can facilitate diagnostic and interventional imaging," added Kimmel.
Each year the CMEF show is supported by Varian's Pan Pacific sales group with facilities located in Beijing and Shanghai, China. The Pan Pacific group works with Chinese OEM's and also sells new replacement X-ray tubes and flat panel detectors throughout the region. Their customers are primarily local manufacturers, independent service organizations and asset management groups that support a wide variety of imaging equipment.
Varian will also demonstrate advanced radiation oncology technology for making treatments faster, more accurate, and easier to plan and deliver. The demonstration will include the TrueBeam™ system for image-guided radiotherapy and radiosurgery, designed from the ground up to treat tumors with unprecedented speed and accuracy; treatment planning and information management software products, as well as solutions for planning and delivering IMRT, IGRT, and RapidArc™ radiotherapy.
About Varian Medical Systems
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,700 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com or follow us on Twitter.
CONTACT: Elaine Rebele, +1-801-978-5715, email@example.com
Related medicine technology :1
|SOURCE Varian Medical Systems, Inc.|
Copyright©2010 PR Newswire.
All rights reserved
. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial2
. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference3
. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint4
. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania5
. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers6
. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)7
. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer8
. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease9
. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies10
. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer11
. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer